At a glance — estimates of drug use in the European Union (updated June 2022)

Graphic shows estimates of prevalence of use for different drugs in the European Union (EU-27).

This graphic is take from the European Drug Report 2021. Full source data and methods and definitions may be found in the Statistical Bulletin 2021.

Graphic source data is provided below for accessibility and reuse purposes.

Cannabis

Prevalence of cannabis use in the EU, 2019 or most recent year
Age	Last year use	Rate	Lifetime use	Rrate	Lowest	Highest
Adults (15-64)	22.2 million	7.7 %	78.5 million	27.2 %	n.a.	n.a.
Young adults (15-34)	15.8 million	15.4 %	n.a.	n.a.	3.4 %	21.8 %

Cocaine

Prevalence of cocaine use in the EU, 2019 or most recent year
Population	Last year use	Rate	Lifetime use	Rrate	Lowest	Highest
Adults (15-64)	3.5 million	1.2 %	13.8 million	4.8 %	n.a.	n.a.
Young adults (15-34)	2.2 million	2.1 %	n.a.	n.a.	0.2 %	4.6 %

MDMA

Prevalence of MDMA use in the EU, 2019 or most recent year
Population	Last year use	Rate	Lifetime use	Rrate	Lowest	Highest
Adults (15-64)	2.6 million	0.9 %	10.4 million	3.6 %	n.a.	n.a.
Young adults (15-34)	2.0 million	1.9 %	n.a.	n.a.	0.2 %	8.5 %

Amphetamines

Prevalence of amphetamines use in the EU, 2019 or most recent year

Population	Last year use	Rate	Lifetime use	Rrate	Lowest	Highest
Adults (15-64)	2.0 million	0.7 %	8.7 million	3.0 %	n.a.	n.a.
Young adults (15-34)	1.4 million	1.4 %	n.a.	n.a.	0.0 %	4.1 %

Heroin and other opioids

Drug	High-risk opioid users	OST clients	Drug treatment requests	Opioids in fatal overdoses
Opioids	1 million	510 000	26%	76%

June 2022

CC-BY-4.0

Download (0.35 MB)

Related assets in the Media library